Dispelling Dampness, Relieving Turbidity and Dredging Collaterals Decoction, Attenuates Potassium Oxonate-Induced Hyperuricemia in Rat Models

Overview

Journal Drug Des Devel Ther

Specialty Pharmacology

Date 2023 Aug 8

PMID 37551408

Authors

Hai-Bo Liu

Min Yang

Wan Li

Ting Luo

Yang Wu

Xiang-Yu Huang

Yao-Lei Zhang

Tao Liu

Yong Luo

Affiliations

Soon will be listed here.

Abstract

Purpose: Dispelling dampness, relieving turbidity and dredging collaterals decoction (DED), is a traditional Chinese medicine used in the treatment of hyperuricemia. We aimed to explore the effect and mechanism of DED in the treatment of hyperuricemia.

Methods: The effects of DED (9.48, 4.74, and 2.37 g/kg/d) on potassium oxonate (750 mg/kg/d)-induced hyperuricemia in rats were evaluated by serum uric acid (UA), creatinine (CRE), blood urea nitrogen (BUN), and renal pathological changes. Network pharmacology was used to identify the effective components and targets of DED, and the key targets and signaling pathways for its effects on hyperuricemia were screened. Molecular docking was used to predict the action of DED. H&E, immunohistochemistry, WB, and PCR were used to validate the network pharmacology results.

Results: DED can effectively alleviate hyperuricemia, inhibit UA, CRE, BUN, and xanthine oxidase (XOD) activity, and reduce renal inflammatory cell infiltration and glomerular atrophy. The experiment identified 27 potential targets of DED for hyperuricemia, involving 9 components: wogonin, stigmasterol 3-O-beta-D-glucopyranoside, 3β-acetoxyatractylone, beta-sitosterol, stigmasterol, diosgenin, naringenin, astilbin, and quercetin. DED can relieve hyperuricemia mainly by inhibiting RAGE, HMGB1, IL17R, and phospho-TAK1, and by regulating the AGE-RAGE and IL-17 signaling pathways.

Conclusion: DED can alleviate hyperuricemia by inhibiting XOD activity and suppressing renal cell apoptosis and inflammation via the AGE-RAGE signaling pathway and IL-17 signaling pathway. This study provides a theoretical basis for the clinical application of DED.

Citing Articles

Analysis of Polyphenol Extract from Hazel Leaf and Ameliorative Efficacy and Mechanism against Hyperuricemia Zebrafish Model via Network Pharmacology and Molecular Docking.

Wang X, Zhao J, Lin Z, Li J, Li X, Xu X Molecules. 2024; 29(2).

PMID: 38257230 PMC: 10820926. DOI: 10.3390/molecules29020317.

References

Liu T, Gao H, Zhang Y, Wang S, Lu M, Dai X . Apigenin Ameliorates Hyperuricemia and Renal Injury through Regulation of Uric Acid Metabolism and JAK2/STAT3 Signaling Pathway. Pharmaceuticals (Basel). 2022; 15(11). PMC: 9697024. DOI: 10.3390/ph15111442. View

Xie W, Yang H, Guo C, Xie R, Yu G, Li Y . Integrated Network Pharmacology and Experimental Validation Approach to Investigate the Mechanisms of in the Treatment of Rheumatoid Arthritis. Drug Des Devel Ther. 2023; 17:691-706. PMC: 10007868. DOI: 10.2147/DDDT.S387570. View

Liu L, Jiang S, Liu X, Tang Q, Chen Y, Qu J . Inflammatory Response and Oxidative Stress as Mechanism of Reducing Hyperuricemia of - with Network Pharmacology. Oxid Med Cell Longev. 2021; 2021:8031319. PMC: 8670933. DOI: 10.1155/2021/8031319. View

Yang B, Xin M, Liang S, Huang Y, Li J, Wang C . Naringenin Ameliorates Hyperuricemia by Regulating Renal Uric Acid Excretion via the PI3K/AKT Signaling Pathway and Renal Inflammation through the NF-κB Signaling Pathway. J Agric Food Chem. 2022; 71(3):1434-1446. DOI: 10.1021/acs.jafc.2c01513. View

Liu H, Peng S, Yuan H, He Y, Tang J, Zhang X . Chinese herbal medicine combined with western medicine for the treatment of type 2 diabetes mellitus with hyperuricemia: A systematic review and meta-analysis. Front Pharmacol. 2023; 14:1102513. PMC: 9902346. DOI: 10.3389/fphar.2023.1102513. View

Liu D, Yan J, Guo M, Luo Y, Yang M, Yang M . Effect of methotrexate combined with Sanhuang Yilong decoction on serum and synovial fluid aquaporin levels in rheumatoid arthritis dampness-heat blockage syndrome. J Tradit Chin Med. 2020; 38(4):618-624. View

Vargas-Santos A, Neogi T . Management of Gout and Hyperuricemia in CKD. Am J Kidney Dis. 2017; 70(3):422-439. PMC: 5572666. DOI: 10.1053/j.ajkd.2017.01.055. View

Ferraz-Filha Z, Carolina de Paula Michel Araujo M, Ferrari F, Dutra I, Saude-Guimaraes D . Tabebuia roseoalba: In Vivo Hypouricemic and Anti-inflammatory Effects of Its Ethanolic Extract and Constituents. Planta Med. 2016; 82(16):1395-1402. DOI: 10.1055/s-0042-105878. View

Qian Y, Yin J, Ni J, Chen X, Shen Y . A Network Pharmacology Method Combined with Molecular Docking Verification to Explore the Therapeutic Mechanisms Underlying Simiao Pill Herbal Medicine against Hyperuricemia. Biomed Res Int. 2023; 2023:2507683. PMC: 9935928. DOI: 10.1155/2023/2507683. View

10.

Huang J, Lin Z, Wang Y, Ding X, Zhang B . Wuling San Based on Network Pharmacology and in vivo Evidence Against Hyperuricemia via Improving Oxidative Stress and Inhibiting Inflammation. Drug Des Devel Ther. 2023; 17:675-690. PMC: 9994669. DOI: 10.2147/DDDT.S398625. View

11.

Amatjan M, Li N, He P, Zhang B, Mai X, Jiang Q . A Novel Approach Based on Gut Microbiota Analysis and Network Pharmacology to Explain the Mechanisms of Action of L. Formula in the Improvement of Hyperuricemic Nephropathy in Rats. Drug Des Devel Ther. 2023; 17:107-128. PMC: 9880016. DOI: 10.2147/DDDT.S389811. View

12.

Heel R, Brogden R, Speight T, Avery G . Benzbromarone: a review of its pharmacological properties and therapeutic use in gout and hyperuricaemia. Drugs. 1977; 14(5):349-66. DOI: 10.2165/00003495-197714050-00002. View

13.

Schloss J, Ryan K, Steel A . Corrigendum to A randomised, double-blind, placebo-controlled clinical trial found that a novel herbal formula UROX® BEDTIME BUDDY assisted children for the treatment of nocturnal enuresis. Phytomedicine (2021) 153783.... Phytomedicine. 2022; 99:153992. DOI: 10.1016/j.phymed.2022.153992. View

14.

Chen D, Li Q, Zhang H, Kou F, Li Q, Lyu C . Traditional Chinese medicine for hypertrophic scars-A review of the therapeutic methods and potential effects. Front Pharmacol. 2022; 13:1025602. PMC: 9589297. DOI: 10.3389/fphar.2022.1025602. View

15.

Yang L, Wang B, Ma L, Fu P . Traditional Chinese herbs and natural products in hyperuricemia-induced chronic kidney disease. Front Pharmacol. 2022; 13:971032. PMC: 9395578. DOI: 10.3389/fphar.2022.971032. View

16.

Becker M, Schumacher Jr H, Wortmann R, MacDonald P, Eustace D, Palo W . Febuxostat compared with allopurinol in patients with hyperuricemia and gout. N Engl J Med. 2005; 353(23):2450-61. DOI: 10.1056/NEJMoa050373. View

17.

Yang M, Guo M, Luo Y, Yun M, Yan J, Liu T . Effect of Artemisia annua extract on treating active rheumatoid arthritis: A randomized controlled trial. Chin J Integr Med. 2016; 23(7):496-503. DOI: 10.1007/s11655-016-2650-7. View

18.

Hou C, Sha W, Xu Z, Hu Y, Amakye W, Yao M . Culture and establishment of self-renewing human liver 3D organoids with high uric acid for screening antihyperuricemic functional compounds. Food Chem. 2021; 374:131634. DOI: 10.1016/j.foodchem.2021.131634. View

19.

Qian X, Jiang Y, Luo Y, Jiang Y . The Anti-hyperuricemia and Anti-inflammatory Effects of Atractylodes Macrocephala in Hyperuricemia and Gouty Arthritis Rat Models. Comb Chem High Throughput Screen. 2022; 26(5):950-964. DOI: 10.2174/1386207325666220603101540. View

20.

Linani A, Serseg T, Benarous K, Bou-Salah L, Yousfi M, Alama M . L. flavonoids as potent inhibitors to xanthine oxidase: in vitro, molecular docking, ADMET and PASS studies. J Biomol Struct Dyn. 2022; 41(15):7055-7068. DOI: 10.1080/07391102.2022.2114943. View